Oral Glucose Tolerance Test and Post Partum Diagnosis of Diabetes Mellitus, Type 2 (DT2 Post-Partum)

Descriptive Study of the Diabetes Mellitus, Type 2 Diagnosis Methods During Postpartum Period in Patients With Medical History of Gestational Diabetes Whom Benefited an Educational Therapy Session.

Sponsors

Lead Sponsor: Hospices Civils de Lyon

Source Hospices Civils de Lyon
Brief Summary

Diabetes mellitus, type 2, is a chronic disease which can be linked with many complications in connexion with impaired blood glucose balance.

It diagnosis in risky subjects such as in patients with medical history of gestational diabetes is therefore imperative to prevent its complications.

Actual guidelines recommend an oral tolerance glucose test, measuring glucose levels after oral glucose intake (75g), between 6 an 12 weeks after childbirth. But studies reveal a low diagnosis rate.

The study of the current practices of diagnosis methods seem to be essential in order to improve this diagnosis.

Overall Status Completed
Start Date October 30, 2018
Completion Date February 13, 2019
Primary Completion Date February 13, 2019
Study Type Observational
Primary Outcome
Measure Time Frame
Performing oral glucose tolerance test in order to detect type 2 diabetes Month 6
Enrollment 173
Condition
Intervention

Intervention Type: Other

Intervention Name: frequency of diabetes mellitus, type 2, diagnosis in patients with medical history of gestational diabetes.

Description: Patients will be contacted by mail with sending of the information notice to ask them to participate in the study. If they don't reply, the subjects will be called by phone by the investigator to collect their non opposition of participation at the study. During this call, the investigator will be able to answer all the questions about the study. The report of this telephone conversation will be register in the medical file of the patient. Then, we will collect informatic data from the hospital concerning the patients. After that they will be contacted by phone to answer a survey. Beside, another secure survey will be send by email to each patient's family doctor. To finish, crossing data between those of the patients and the family doctor and anonymisation of the data.

Arm Group Label: Women with medical history of gestational diabetes

Other Name: Evaluate the frequency of diabetes mellitus, type 2, diagnosis with an oral glucose tolerance test between 6 and 12 weeks after childbirth in patients with medical history of gestational diabetes.

Eligibility

Sampling Method: Non-Probability Sample

Criteria:

Inclusion Criteria:

- Patients followed in endocrinology at the hospital of Vienne for gestational diabetes, whom benefited an educational therapy session between the 01/01/2016 and the 31/12/2016 inclusive.

Exclusion Criteria:

- Minor patients or under legal protection (guardianship)

- Patients who not speak french

- Patients who did not declared an attending physician

- Refusal to take part in the survey

- Patients lost to follow-up before childbirth

- Patients whose pregnancy ended by foetal death.

- Pre-existing diabet before pregnancy

Gender: Female

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: No

Overall Official
Last Name Role Affiliation
Laura BOGENMANN, MD Study Director Centre Hospitalier de Vienne
Location
Facility: Centre hospitalier Lucien Hussel
Location Countries

France

Verification Date

August 2019

Responsible Party

Type: Sponsor

Has Expanded Access No
Condition Browse
Arm Group

Label: Women with medical history of gestational diabetes

Description: Patients followed at the hospital of Vienne for gestational diabetes in 2016.

Study Design Info

Observational Model: Cohort

Time Perspective: Retrospective

Source: ClinicalTrials.gov